Group One Trading
ENTA icon

Group One Trading’s Enanta Pharmaceuticals ENTA Stock Holding History

Group One Trading’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53K Sell
200
-100
-33% -$1.34K ﹤0.01% 6978
2025
Q4 		$4.73K Sell
300
-900
-75% -$11.4K ﹤0.01% 7205
2025
Q3 		$14.4K Buy
1,200
+900
+300% +$7.19K ﹤0.01% 6933
2025
Q2 		$2.27K Buy
+300
New +$1.8K ﹤0.01% 7382
2022
Q1 		– Sell
-14,200
Closed -$1.06M – 8191
2021
Q4 		$1.06M Buy
+14,200
New +$1.11M ﹤0.01% 3298
2020
Q3 		– Sell
-3,200
Closed -$161K – 6197
2020
Q2 		$161K Hold
3,200
– – ﹤0.01% 3557
2020
Q1 		$165K Buy
+3,200
New +$171K ﹤0.01% 2904
2015
Q3 		– Sell
-2,500
Closed -$112K – 4928
2015
Q2 		$112K Hold
2,500
– – ﹤0.01% 2993
2015
Q1 		$77K Buy
+2,500
New +$97.3K ﹤0.01% 3073
2014
Q4 		– Sell
-300
Closed -$12K – 4983
2014
Q3 		$12K Hold
300
– – ﹤0.01% 4373
2014
Q2 		$13K Hold
300
– – ﹤0.01% 4404
2014
Q1 		$12K Buy
+300
New +$10.9K ﹤0.01% 4496

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Group One Trading's ENTA Position: Q1 2026 in Review

Group One Trading opened a new position in Enanta Pharmaceuticals (ENTA) in Q1 2026: 91 shares worth $1.15K. The stake represents ﹤0.01% of the portfolio and ranks #7195 among its holdings. This is a return to the name: Group One Trading previously reported a position in ENTA as recently as Q3 2025.

Group One Trading first reported a position in ENTA in Q1 2014 and has held it in 20 quarters since. The position peaked at $208K in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Group One Trading held 91 shares of Enanta Pharmaceuticals worth $1.15K as of Q1 2026.
  • Enanta Pharmaceuticals was a new Group One Trading position in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7195 holding.
  • Group One Trading first reported a position in Enanta Pharmaceuticals in Q1 2014 and has held it in 20 quarters since.
  • Group One Trading's Enanta Pharmaceuticals position peaked at $208K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.